To date, the molecular basis for the cooperation between PI3K and YAP signaling in liver cancer is not well understood, but could be mediated be PI3K-induced upregulation of CD166, a cell surface protein that has been shown to positively regulate YAP activity (Ma et al., 2014). Here, PIK3CA is linked to liver cancer.